LEFT SIDED COLORECTAL CANCER

Clinical trials for LEFT SIDED COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new LEFT SIDED COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for LEFT SIDED COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for colorectal cancer: amivantamab combo tested in 1,000 patients

Disease control Recruiting now

This study compares two drug combinations for people with advanced left-sided colorectal cancer that cannot be removed by surgery. Participants receive either amivantamab or cetuximab along with chemotherapy. The goal is to see which combination helps keep the cancer from growing…

Matched conditions: LEFT SIDED COLORECTAL CANCER

Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

LEFT SIDED COLORECTAL CANCER

Get alerted when new LEFT SIDED COLORECTAL CANCER trials appear

New hope for colorectal cancer: amivantamab combo tested in 1,000 patients